The company aims to conduct research, development, production, and commercialization of innovative and scalable technology and life sciences solutions related to human health, well-being, and performance. This includes medical devices, hardware systems, data-based products, software, services, intellectual property, and all related or supporting activities. The company may establish branches and subsidiaries in Switzerland and/or abroad, invest in other companies in Switzerland and/or abroad, acquire, hold, encumber, and dispose of real estate or intellectual property rights in Switzerland and/or abroad, and conduct all commercial, financial, or other transactions directly or indirectly related to the company's purpose. Furthermore, the company may grant loans or other financing to its direct or indirect shareholders, their direct or indirect subsidiaries, and third parties, either for a fee or free of charge, and provide security for the liabilities of such persons or group companies in various forms, including guarantees, pledges, and fiduciary transfers of the company's assets. Additionally, the company may engage in or participate in liquidity equalization/net liquidity centralization (cash pooling) with group companies, as well as periodic balance adjustments (balancing), all without consideration, at preferential terms, interest-free, without the intention of making a profit for the company, and assuming clustering risks.
Outbound Leads by COHAGA